ArticleMolecular horticulture2026
PsGA2ox2 is a novel target of miR159 involved in endodormancy regulation in tree peony (Paeonia suffruticosa).
Article in Molecular horticulture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In deciduous woody plants, buds enter endodormancy in late autumn, and endodormancy release (EDR) is a essential for regrowth. In tree peony, endodormancy is a major obstacle to forcing culture, an important component of its industry. Both chilling accumulation and gibberellin acid (GA) application can contribute to break dormancy and facilitate bud sprouting and flowering under appropriate conditions. PsmiR159b is one of the most abundant miRNAs in dormant buds, targeting PsMYB65 to inhibit bud EDR. Here, PsGA2ox2 was identified as a novel target of PsmiR159b according to expression data and genetic analysis. PsGA2ox2 expression was up-regulated by prolonged chilling, following with an increase of gibberellic acid 34 (GA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.